Pharmaceutical Technology

JUNE 16, 2023

The Abu Dhabi Department of Health (DoH) in the UAE has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance life sciences.

Life Science 130

Life Science Genetic Disease Genomics Genome 130

Pharmaceutical Technology

NOVEMBER 8, 2022

Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. A commercial-stage biopharmaceutical firm, Oyster Point discovers, develops and commercialises therapies for treating ophthalmic ailments.

Life Science 147

Life Science Sales Development Drugs 147

XTalks

OCTOBER 18, 2022

In order to prosper, life science organizations need innovators, strategists, researchers, visionaries and more to build a workforce that demonstrates real value for patient outcomes. Are you looking to understand the powerful impact HR has on the overall success of the global life science industry?

HR 104

HR Life Science Development Research 104

pharmaphorum

JANUARY 6, 2023

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023. Simplicity and technology intersect to streamline drug development.

Life Science 111

Life Science Development Research Production 111

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

Life Science 115

Life Science Development Drugs Research 115

Pharmaceutical Technology

JULY 28, 2022

In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Industry clusters.

Life Science 130

Life Science Marketing Production Research 130

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. This will improve accessibility to services for AAV-mediated gene therapy programmes.

Gene Therapy 256

Gene Therapy Gene Development Manufacturing 256

XTalks

FEBRUARY 15, 2024

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. Wright’s work on patient biopsy samples led to the groundbreaking use of chemotherapy as a viable cancer treatment.

Life Science 115

Life Science Scientist Research Protein 115

XTalks

FEBRUARY 14, 2024

This episode features an interview with Yang Liu, PhD, founder, chairman, CEO and chief scientific officer; and Abid Ansari, MBA, Chief Financial Officer at OncoC4 , a clinical-stage biopharmaceutical company focused on developing novel treatments for cancer. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 119

Life Science DNA Production Clinical Trials 119

XTalks

FEBRUARY 14, 2023

The life science industry is constantly evolving, making it difficult to stay ahead of the curve. There’s no doubt that pharmaceutical and biotechnology organizations are utilizing innovative technology solutions across all sectors of drug development, research and development, supply chain, manufacturing and more.

Life Science 98

Life Science Clinical Trials Clinical Trials Development 98

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

SEPTEMBER 12, 2023

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. IBM will also provide its knowledge to help Moderna explore the potential use cases of quantum technologies in life sciences.

Research 246

Research Gene Therapy Gene Scientist 246

Cloudbyz

MARCH 17, 2024

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

Life Science 81

Life Science Clinical Trials Clinical Trials Trials 81

Pharmaceutical Technology

FEBRUARY 13, 2023

While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. Meanwhile, others are researching the link between gene variation and different responses to treatments.

Research 264

Research Gene Gene Therapy Genomics 264

XTalks

JULY 5, 2023

Established in 2018, CytoMed is a biotechnology firm that originated from the Agency for Science, Technology and Research (A*STAR), Singapore’s premier public sector research and development agency. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 97

Life Science Development Engineer Scientist 97

XTalks

SEPTEMBER 6, 2023

David Young, founder and President R&D at Processa Pharmaceuticals, a clinical-stage pharmaceutical company developing personalized approaches to cancer treatments with a focus on next generation chemotherapy drugs with improved safety and efficacy. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 116

Life Science Drugs Development Research 116

XTalks

JUNE 9, 2023

Consistency is a key factor in any successful life science content marketing strategy. Maintaining consistency throughout the content you develop is essential to establish credibility and loyalty. Let’s explore why and how consistency can play a vital role in the success of B2B life science content marketing.

Life Science 98

Life Science Marketing Branding Production 98

Cloudbyz

MAY 17, 2024

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation. first appeared on CLOUDBYZ.

Life Science 102

Life Science Clinical Trials Clinical Trials Trials 102

Pharmaceutical Technology

OCTOBER 6, 2022

BioLink Life Sciences has received a contract worth $750,000 from the US Biomedical Advanced Research and Development Authority (BARDA) to develop Ramatroban for treating Covid-19 pneumonia patients in the hospital setting. The trial will also lay the ground for additional trials for acute and long Covid in the US.

Development 162

Development Life Science Immune Response Trials 162

Pharmaceutical Technology

MAY 16, 2023

The Foundation for the National Institutes of Health (FNIH) has announced its plans to prioritise eight rare diseases to provide industry standards for manufacturing, preclinical testing and product analytical testing for gene therapy development.

Gene Therapy 227

Gene Therapy Gene Research Clinical Trials 227

XTalks

APRIL 21, 2023

The company claimed to have developed a revolutionary blood testing technology that could detect a wide range of diseases with just a few drops of blood. Theranos’ groundbreaking developments received many patents. Life science startups face unique challenges given the highly regulated and complex nature of the industry.

Life Science 98

Life Science Trials Production Regulation 98

BioSpace

JUNE 5, 2024

Securing top talent in research and development and manufacturing will remain challenging for life sciences companies in 2024, according to a new report by CBRE.

Life Science 69

Life Science Manufacturing Development Research 69

XTalks

FEBRUARY 15, 2023

Bastiaan Driehuys, PhD Founder and Chief Technology Officer Polarean Imaging plc In this week’s Xtalks Life Science podcast episode, Ayesha and the editorial team spoke with Dr. Bastiaan Driehuys, Founder and Chief Technology Officer at Polarean Imaging plc. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 98

Life Science FDA Approval Drugs Production 98

Pharmaceutical Technology

NOVEMBER 4, 2022

In June, the Association of the British Pharmaceutical Industry (ABPI) sent an open letter to the Conservative leadership, including Truss and Sunak, which warned that the UK is slipping behind its global competitors in the race to become a life sciences superpower. UK clinical trials industry.

Life Science 234

Life Science Clinical Trials Clinical Trials Trials 234

Pharmaceutical Technology

NOVEMBER 17, 2022

Horizon Therapeutics and Johns Hopkins University School of Medicine have entered a multi-year scientific partnership for advancing autoimmunity and inflammation research. The collaboration will work on identifying new disease targets and developing therapies to treat serious autoimmune and inflammatory conditions.

Research 130

Research Life Science Medicine Development 130

Pharmaceutical Technology

NOVEMBER 3, 2022

Emalex Biosciences has raised Series D funds worth $250m led by Bain Capital Life Sciences to progress the development of an investigational new drug for Tourette syndrome. Paragon Biosciences, Valor Equity Partners, Fidelity Management & Research Company and various family offices took part in the financing round.

Development 130

Development Drugs Clinical Trials Clinical Trials 130

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. This included more than £6bn ($7.3bn) being made available by the UK Government in November 2020 for the development and procurement of successful vaccines.

Vaccine 234

Vaccine Vaccination Bacteria Life Science 234

Pharmaceutical Technology

OCTOBER 20, 2022

PIC Therapeutics has raised $35m in a Series A funding round led by OrbiMed to develop therapies for drug-resistant breast cancer. The funding round saw participation from current investors of the company, Advent Life Sciences and Belinda Termeer. This drug is an allosteric protein translation modulator that acts on eIF4E.

Development 130

Development Drugs Protein Life Science 130

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Development Genetic Disease 225

Pharmaceutical Technology

APRIL 21, 2023

Samyang has entered into a strategic partnership agreement with LG Chem to develop new cancer therapeutics using Samyang’s technology, NanoReady. LG Chem will use the technology for the development of innovative mRNA-based cancer therapeutics with maximised therapeutic efficacy.

Development 130

Development Gene Therapy Drug Delivery Gene 130

Pharmaceutical Technology

DECEMBER 14, 2022

Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications. The firms intend to merge their expertise to provide simplified viral vector gene therapy development, production and testing in Japan.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. Personalised medicines will also be developed at the centre.

Gene Therapy 264

Gene Therapy Manufacturing Gene Clinical Trials 264

pharmaphorum

JULY 24, 2024

Explore the latest developments in the life sciences industry with a focus on patient-centred research and development (R&D) at DIA 2024. Chart new horizons and stay updated on key trends shaping the future of healthcare.

Life Science 111

Life Science Development Research 111

Medical Xpress

MARCH 8, 2023

The research group led by Prof. Zeng Zhutian from the Division of Life Sciences and Medicine of the University of Science and Technology of China (USTC) revealed a new mechanism of immune surveillance by liver-resident macrophages called Kupffer cells (KCs) that prevent liver metastasis from occurring.

Development 92

Development Scientist Life Science Medicine 92

XTalks

JANUARY 16, 2024

There are other challenges facing CNS drug development, for example, higher-than-average patient drop-out rates due to the burden associated with attending clinical site visits. CJ Barnum, PhD, Vice President of CNS Development, INmune Bio, Inc. about various aspects of CNS drug development.

Development 122

Development Drugs Clinical Trials Clinical Trials 122